Research & Development

The ability to peer into the biological future of a patient by predicting how a radioactive drug will distribute through their unique anatomy represents a monumental leap in the fight against advanced prostate cancer. The field of oncology is currently navigating a fundamental shift where treatment

The persistent challenge of treating non-small cell lung cancer lies not in the absence of potent therapeutic agents but in the inherent difficulty of delivering these treatments exclusively to malignant cells while preserving the integrity of surrounding healthy pulmonary tissue. Modern oncology

Patients diagnosed with metastatic colorectal cancer carrying the BRAF V600E mutation have long navigated a clinical landscape where conventional chemotherapy often fails to provide lasting control over their disease. This specific genetic signature, found in approximately ten percent of metastatic

The recent publication of a comprehensive feline cancer genomic atlas provides an unprecedented view into the molecular commonalities that link domestic cats and humans, offering transformative insights into how oncogenic processes evolve across mammalian species. This mapping effort involved the

The daunting reality of high-risk localized prostate cancer is that surgical intervention often feels like an incomplete solution, especially when half of patients face a biological recurrence within just five years of their primary treatment. This aggressive form of the disease, which accounts for

The moment a physician can decode the specific genetic vulnerabilities of a tumor marks the beginning of a profound shift in how the medical community approaches the most aggressive forms of human disease. At the 2026 American Society for Clinical Oncology Annual Meeting, the focus transitioned